EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

MRI features that predict progression of residual disease after ablation of extra-abdominal desmoid fibromatosis

Daniel M Düx, Yosef Chodakiewitz, Rachelle Bitton, Sharmila Sewell, Vipul R Sheth, Pejman Ghanouni, Ryan L Brunsing

European Radiology · 21.01.2025 · 35 (7) · 4161-4170

DOI: 10.1007/s00330-024-11319-w ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Radiology, online erschienen am 21.01.2025. Verfasst von Daniel M Düx und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Hannover Medical School (MHH), Carl-Neuberg-Straße 1, 30625, Hannover, Germany. duex.daniel@mh-hannover.de. Hauptthemen laut MEDLINE: Desmoid Tumors, Magnetic Resonance Imaging, Ablation Techniques. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Focused Ultrasound Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To identify MRI features of desmoid tumors (DTs) that predict the growth of residual disease following ablation.

Methods

Patients who underwent MRI-guided ablation for DTs between February 2013 and April 2021 were included in this single-center IRB-approved retrospective study. MRI scans assessed three suspicious tissue features: intermediate T2 signal [+iT2], nodular appearance [+NOD], and contrast enhancement [+ENH]. Percent-monthly change in diameter (PMCD) of suspicious foci determined growth (PMCD > 1%), unchanged (PMCD between −1% and +1%), or regression (PMCD < −1%). Statistical tests compared mean PMCD between groups and evaluated sensitivity and specificity.

Results

Thirty-three patients (32 years ± 13.3; 22 females) with 34 DTs underwent 47 MRI-guided ablations, with a median follow-up of 269 days (IQR 147). Of 93 suspicious foci, 62 (67%) grew (PMCD: +5.6% IQR: 5.8), 13 (14%) remained unchanged (PMCD: −0.1% IQR: 0.6), and 18 (19%) regressed (PMCD: −3.9% IQR: 4.2). Features [+iT2], [+ENH], and [+NOD] were associated with PMCDs of +5.2% IQR: 6.0, +3.4% IQR: 6.0, and +3.4% IQR: 6.5, respectively, compared to −1.5% IQR: 4.7 ( p < 0.0001), −0.5% IQR: 0.8 ( p = 0.003), and +0.4% IQR: 7.5 ( p = 0.0056) for their respective negative counterparts. Sensitivity, specificity, and accuracy for distinguishing growth were [+iT2]: 0.95, 0.71, 0.87, [+ENH]: 1.00, 0.32, 0.77, and [+NOD]: 0.84, 0.42, 0.70. Combining [+iT2 + NOD + ENH] yielded PMCD +5.9% IQR: 6.2 and the best performance for distinguishing growth (sensitivity 0.81, specificity 0.94, accuracy 0.85).

Discussion

MRI features reliably predict the growth of residual or recurrent DTs post-ablation, with [+iT2] being the most accurate. Adding nodular enhancement to [+iT2] improved specificity without sacrificing accuracy. Key Points Question Post-ablation imaging of desmoids is challenging due to tumor heterogeneity and treatment-related inflammation. This study evaluates MRI features for assessing future tumor growth.

Findings

Foci of intermediate T2 signal post-ablation predicted desmoid growth with high sensitivity (0.95), while T2 signal, nodularity, and enhancement combined offer high specificity (0.94). Clinical relevance Intermediate T2 signal predicts desmoid tumor growth post-ablation with high sensitivity and accuracy but moderate specificity. Combining nodularity and enhancement improves specificity and predictive value, helping clinicians in managing desmoid tumor patients post-ablation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Desmoid TumorsMagnetic Resonance ImagingAblation TechniquesHumansFemaleAdultMaleRetrospective StudiesNeoplasm, ResidualDisease ProgressionSensitivity and SpecificityMiddle AgedAdolescentPredictive Value of TestsContrast MediaYoung Adult

Stichwörter der Autor:innen

Ablation techniquesFibromatosis (aggressive)Magnetic resonance imagingMusculoskeletal diseasesNeoplasms (connective and soft tissue)

Substanzen

Contrast Media

Autor:innen und Institutionen

  • Department of Radiology, Hannover Medical School (MHH), Carl-Neuberg-Straße 1, 30625, Hannover, Germany. duex.daniel@mh-hannover.de.
  • Department of Radiology, Stanford School of Medicine, Stanford, CA, 94305, USA.

Förderung

  • Focused Ultrasound Foundation

Zitieren

APA

Düx, D. M., Chodakiewitz, Y., Bitton, R., Sewell, S., Sheth, V. R., Ghanouni, P., & Brunsing, R. L. (2025). MRI features that predict progression of residual disease after ablation of extra-abdominal desmoid fibromatosis. European Radiology, 35(7), 4161-4170. https://doi.org/10.1007/s00330-024-11319-w

Vancouver

Düx DM, Chodakiewitz Y, Bitton R, Sewell S, Sheth VR, Ghanouni P, et al. MRI features that predict progression of residual disease after ablation of extra-abdominal desmoid fibromatosis. European Radiology. 2025;35(7):4161-4170. doi:10.1007/s00330-024-11319-w

BibTeX
@article{Dx2025,
  author = {Düx, Daniel M and Chodakiewitz, Yosef and Bitton, Rachelle and Sewell, Sharmila and Sheth, Vipul R and Ghanouni, Pejman and Brunsing, Ryan L},
  title = {MRI features that predict progression of residual disease after ablation of extra-abdominal desmoid fibromatosis},
  journal = {European Radiology},
  year = {2025},
  volume = {35},
  number = {7},
  pages = {4161--4170},
  doi = {10.1007/s00330-024-11319-w}
}
Kostenlos starten →